Carbon nanomaterials have attracted researchers in pharmaceutical applications due to their outstanding properties and flexible dimensional structures. Carbon nanomaterials (CNMs) have electrical properties, high thermal surface area, and high cellular internalization, making them suitable for drug and gene delivery, antioxidants, bioimaging, biosensing, and tissue engineering applications. There are various types of carbon nanomaterials including graphene, carbon nanotubes, fullerenes, nanodiamond, quantum dots and many more that have interesting applications in the future. The functionalization of the carbon nanomaterial surface could modify its chemical and physical properties, as well as improve drug loading capacity, biocompatibility, suppress immune response and have the ability to direct drug delivery to the targeted site. Carbon nanomaterials could also be fabricated into composites with proteins and drugs to reduce toxicity and increase effectiveness in the pharmaceutical field. Thus, carbon nanomaterials are very effective for applications in pharmaceutical or biomedical systems. This review will demonstrate the extraordinary properties of nanocarbon materials that can be used in pharmaceutical applications.

Quinolone antibiotic is known for its effectiveness in treating infectious disease, and has been used widely for humans and also in animals. Continuous use of antibiotics could promote antibiotic resistance as well as result in the accumulation of antibiotic residues in food. Therefore, monitoring the quinolone antibiotic is important. Meanwhile, carbon‐based electrode is known as a material that has been used widely for electrochemical sensor application. It has been used in its bare form and modified form to improve the electrode catalytic performance. In this review, we summarize the utilization of unmodified and modified carbon‐based electrode in detecting various types of quinolone antibiotics. It is expected to provide comprehensive information on related topics.